Stock INTS INTENSITY THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Intensity Therapeutics, Inc.

Equities

INTS

US45828J1034

Real-time Estimate Cboe BZX
Other stock markets
 09:23:00 10/05/2024 pm IST 		5-day change 1st Jan Change
4.06 USD +7.98% Intraday chart for Intensity Therapeutics, Inc. +8.81% -50.99%
05:22pm Intensity Therapeutics Collaborates With Swiss Group on Clinical Research for Breast Cancer Trial MT
19/04 Intensity Therapeutics, Inc. Announces Resignation of Daniel Donovan from Audit Committee of the Board of Directors CI

Evolution of the average Target Price on Intensity Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

5b846e735ed68f665edaa95f76f.WgdHafcEYyFbsn73wuZs8oO3yvx45lXtnwzjZFZ6Q_4.NjQgOo82GxRvxgvPrZ4UusbehKYupACJ-kKWPDEOFsxtY39drnUpexWBKw~f23f08996ce8c861e644f2e990536b28

Analyst Recommendations on Intensity Therapeutics, Inc.

Benchmark Initiates Intensity Therapeutics at Speculative Buy With $12 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.76 USD
Average target price
12 USD
Spread / Average Target
+219.15%
High Price Target
12 USD
Spread / Highest target
+219.15%
Low Price Target
12 USD
Spread / Lowest Target
+219.15%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Intensity Therapeutics, Inc.

Benchmark Company

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. INTS Stock
  4. Consensus Intensity Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW